Dr. Bratslavsky on the Evaluation and Management of Kidney Cancer

Gennedy Bratslavsky, MD
Published: Monday, May 15, 2017



Gennedy Bratslavsky, MD, deputy director of Upstate Cancer Center, director of the Robotic Program for all Upstate Campuses, and director of the VHL Clinical Cancer Center, discusses the evaluation and management of kidney cancer.

Not every patient who presents with bilateral kidney cancer will have a genetic disorder, explains Bratslavsky.

Having knowledge of a specific histology from a biopsy, may help further direct the patient to additional genetic testing.

SELECTED
LANGUAGE


Gennedy Bratslavsky, MD, deputy director of Upstate Cancer Center, director of the Robotic Program for all Upstate Campuses, and director of the VHL Clinical Cancer Center, discusses the evaluation and management of kidney cancer.

Not every patient who presents with bilateral kidney cancer will have a genetic disorder, explains Bratslavsky.

Having knowledge of a specific histology from a biopsy, may help further direct the patient to additional genetic testing.




View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: How to Use Liquid Biopsies Throughout the Lung Cancer Treatment Continuum OnlineJan 31, 20191.5
Community Practice Connections™: Current Status and the Future Potential of CAR T-Cell Therapy for Lymphoid Malignancies: The Experts Weigh-In on Recent Data and Clinical ExperienceJan 31, 20192.0
Publication Bottom Border
Border Publication
x